OliX Pharmaceuticals Statistics
Total Valuation
KOSDAQ:226950 has a market cap or net worth of KRW 1.07 trillion. The enterprise value is 1.09 trillion.
Market Cap | 1.07T |
Enterprise Value | 1.09T |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:226950 has 19.78 million shares outstanding. The number of shares has increased by 15.29% in one year.
Current Share Class | 19.78M |
Shares Outstanding | 19.78M |
Shares Change (YoY) | +15.29% |
Shares Change (QoQ) | +7.27% |
Owned by Insiders (%) | 18.36% |
Owned by Institutions (%) | 15.46% |
Float | 16.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 182.45 |
PB Ratio | 41.35 |
P/TBV Ratio | 45.30 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -23.98 |
EV / Sales | 185.45 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -31.69 |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.10.
Current Ratio | 0.73 |
Quick Ratio | 0.59 |
Debt / Equity | 1.10 |
Debt / EBITDA | n/a |
Debt / FCF | -0.83 |
Interest Coverage | -6.18 |
Financial Efficiency
Return on equity (ROE) is -144.63% and return on invested capital (ROIC) is -26.27%.
Return on Equity (ROE) | -144.63% |
Return on Assets (ROA) | -21.27% |
Return on Invested Capital (ROIC) | -26.27% |
Return on Capital Employed (ROCE) | -60.54% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.07 |
Inventory Turnover | 0.40 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +283.48% in the last 52 weeks. The beta is 0.81, so KOSDAQ:226950's price volatility has been lower than the market average.
Beta (5Y) | 0.81 |
52-Week Price Change | +283.48% |
50-Day Moving Average | 46,181.00 |
200-Day Moving Average | 29,432.20 |
Relative Strength Index (RSI) | 62.15 |
Average Volume (20 Days) | 530,338 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:226950 had revenue of KRW 5.89 billion and -45.52 billion in losses. Loss per share was -2,613.58.
Revenue | 5.89B |
Gross Profit | 5.62B |
Operating Income | -29.07B |
Pretax Income | -45.46B |
Net Income | -45.52B |
EBITDA | -26.45B |
EBIT | -29.07B |
Loss Per Share | -2,613.58 |
Balance Sheet
The company has 11.54 billion in cash and 28.55 billion in debt, giving a net cash position of -17.02 billion or -860.46 per share.
Cash & Cash Equivalents | 11.54B |
Total Debt | 28.55B |
Net Cash | -17.02B |
Net Cash Per Share | -860.46 |
Equity (Book Value) | 25.97B |
Book Value Per Share | 1,353.57 |
Working Capital | -5.65B |
Cash Flow
In the last 12 months, operating cash flow was -22.29 billion and capital expenditures -12.14 billion, giving a free cash flow of -34.44 billion.
Operating Cash Flow | -22.29B |
Capital Expenditures | -12.14B |
Free Cash Flow | -34.44B |
FCF Per Share | -1,741.39 |
Margins
Gross Margin | 95.50% |
Operating Margin | -493.91% |
Pretax Margin | -772.46% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KOSDAQ:226950 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.29% |
Shareholder Yield | n/a |
Earnings Yield | -4.24% |
FCF Yield | -3.21% |
Stock Splits
The last stock split was on December 3, 2020. It was a forward split with a ratio of 2.
Last Split Date | Dec 3, 2020 |
Split Type | Forward |
Split Ratio | 2 |
Scores
KOSDAQ:226950 has an Altman Z-Score of -0.07. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.07 |
Piotroski F-Score | n/a |